Abstract
TPS9113^ Background: Although trials of adjuvant interferon alfa-2b (IFN alpha-2b) in high-risk melanoma patients suggest improvement in disease-free survival (DFS), a metaanalysis could only show ...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have